ClaytonH. B.SchieveL. A.PetersonH. B., “Ectopic Pregnancy Risk with Assisted Reproductive Technology Procedures,”Obstetrics & Gynecology107, no. 3 (2006): 595–604; PapanikolaouE. G.PozzobonC.KolibianakisE. M., “Incidence and Prediction of Ovarian Hyperstimulation Syndrome in Women Undergoing Gonadotropin-Releasing Hormone Antagonist In Vitro Fertilization Cycles,”Fertility and Sterility85, no. 1 (January 2006): 112–20; GorkemliH.CamusM.ClasenK., “Adnexal Torsion After Gonadotrophin Ovulation Induction for IVF or ICSI and Its Conservative Treatment,”Archives of Gynecology and Obstetrics267, no. 1 (November 2002): 4–6.
3.
BrintonL. A.LambE.MoghissiK., “Ovarian Cancer Risk after the Use of Ovulation-Stimulating Drugs,”Obstetrics & Gynecology103, no. 6 (2004): 1194–1203.
4.
American Society for Reproductive Medicine Web site, available at <http://www.asrm.org> (last visited July 20, 2007).
5.
ShahineL. K.CaugheyA. B., “Preimplantation Genetic Diagnosis: The Earliest Form of Prenatal Diagnosis,”Gynecologic and Obstetric Investigation60, no. 1 (2005): 39–46.
6.
FlugJ., “A Boy or a Girl? The Ethics of Preconception Sex Selection,”Journal of Halakhah and Contemporary Society48 (Fall 2004): 5–27.
7.
Leviticus19:16.
8.
Genesis1:28.
9.
Babylonian Talmud, Berachot 10a.
10.
KookA., Sheilot U'teshuvot Mishpat Kohein (Responsa of the Priestly Law), (Jerusalem: Mosad Harav Kook, 1965): 144.
11.
Babylonian Talmud, Berachot 43a.
12.
SavulescuJ., “Procreative Beneficence: Why We Should Select the Best Children,”Bioethics19, no. 1 (October 2001): 12–28.
13.
Babylonian Talmud, Pesahim 25b.
14.
See, for example, HoltugN., “Against Human Gene Therapy,”Cambridge Quarterly of Healthcare Ethics6, no. 2 (1997): 157–174; BuchananA., “Choosing Who Will Be Disabled: Genetic Intervention and the Morality of Inclusion,”Social Philosophy and Policy13, no. 2 (1996): 18–45; and HoughtonH., “Does Prenatal Diagnosis Discriminate against the Disabled?” in McKieJ., ed., Ethical Issues in Prenatal Diagnosis and Termination of Pregnancy (Melbourne: Center for Human Bioethics, 1994): 97–102.
15.
GillamL., “Prenatal Diagnosis and Discrimination against the Disabled,”Journal of Medical Ethics25, no. 2 (April 1999): 163–171.
16.
WertzD. C.FletcherJ. C., “Feminist Criticism of Prenatal Diagnosis: A Response,”Clinical Obstetrics and Gynecology36, no. 3 (1993): 541–547.
17.
Personal correspondence to GraziRichardDr. as cited in GraziR.WolowelskyJ., “Preimplantation Sex Selection and Genetic Screening in Contemporary Jewish Law and Ethics,”Journal of Assisted Reproduction and Genetics9, no. 4 (1992): 318–322.
18.
See, for example, BaxterC.CumminsR.PolakS., “A Longitudinal Study of Parental Stress and Support: From Diagnosis of Disability to Leaving School,”International Journal of Disability, Development, and Education42, no. 2 (1995): 125–136; CahillB. M.GiddenL. M., “Influence of Child Diagnosis on Family and Parental Functioning: Down Syndrome Versus Other Disabilities,”American Journal of Mental Retardation101, no. 2 (1996): 149–160; FergusonP. M., “Mapping the Family: Disability Studies and the Exploration of Parental Response to Disability,” in AlbrechtG. L.SeelmanK. D.BuryM., eds., Handbook of Disability Studies (Thousand Oaks, CA: Sage Publications, 2001); GallimoreR.WeisnerT. S.KaufmanS. Z., “The Social Construction of Ecocultural Niches: Family Accommodation of Developmentally Delayed Children,”American Journal of Mental Retardation94, no. 3 (1989): 216–230; KraussM. W., “Child-Related and Parenting Stress: Similarities and Differences between Mothers and Fathers of Children with Disabilities,”American Journal of Mental Retardation97, no. 4 (1993): 393–404.
19.
See, for example, SperawS., “Spiritual Experiences of Parents and Caregivers Who Have Children with Disabilities or Special Needs,”Issues in Mental Health Nursing27, no. 2 (February-March 2006): 213–230.
20.
AschA.WassermanD., “Where Is the Sin in Synecdoche? Prenatal Testing and the Parent-Child Relationship,” in WassermanD.BickenbachJ.WachbroitR., eds., Quality of Life and Human Difference Genetic Testing, Health Care, and Disability (New York: Cambridge University Press, 2005): 172–216.
21.
See, for example, BleichJ. D., “Hazardous Medical Procedures,”Tradition37, no. 3 (2003): 76–100; see also EttingerD., Pe'er Tachat Efer (Splendor Under the Dust) (Jerusalem: Devir, 1988): 57–92.
22.
WeinerY., Rapo Yerapai (Surely You Must Heal) (Jerusalem: Jerusalem Center for Research, 1995): 121–134.
23.
Babylonian Talmud, Yevamot 69b.
24.
NebentzalA., “The Rights of Inheritors to Frozen Reproductive Seed,”Techumin17, no. 1 (1993): 347–348.
25.
See, for example, the comments of Rabbi Shmuel Wosner as cited in FreidlanderA., Sefer Chasdei Avraham, Haholeh B'halakhah (Book for the Pious Ones of Abraham, The Sick Person in Jewish Law) (Brooklyn: Hakulmus, 1999): 312–317.
26.
FeinsteinM., Iggrot Moshe (The Letters of Moses), vol. 1 (New York: Moriyah, 1959): At letter 62.
27.
As cited in Nishmat Avraham (The Breath of Abraham), vol. 1 (Jerusalem: Schlesinger Institute, 1992): at 5.
28.
MacklerA., “In Vitro Fertilization,” in AbelsonK.FineD., eds., Responsa: 1991–2000, The Committee on Jewish Law and Standards of the Conservative Movement (New York: The Rabbinical Assembly, 2002): 510–525.
29.
DaichovskyS., “Breira Teremubar U'ma'amado Shel Kedemubar” (Preimplantation Selection and the Status of the Preembryo), Assia20, no. 1 (2006): 73–75.
30.
FrankT. S.DeffenbaughA. M.ReidJ. E., “Clinical Characteristics of Individuals with Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals,”Journal of Clinical Oncology20, no. 6 (March 15, 2002): 1480–90.
31.
BenitoA.DiazM. A.Gonzalez-VicentM., “Hematopoietic Stem Cell Transplantation Using Umbilical Cord Blood Progenitors: Review of Current Clinical Results,”Bone Marrow Transplantation33, no. 7 (2004): 675–690.
32.
TiercyJ. M.Bujan-LoseM.ChapuisB., “Bone Marrow Transplantation with Unrelated Donors: What Is the Probability of Identifying an HLA-A/B/Cw/DRB1/B3/DQB1- Matched Donor?”Bone Marrow Transplantation26, no. 4 (August 2000): 437–441.
33.
WagnerJ. E.DaviesS. M.AuerbachA. D., “Hematopietic Cell Transplantation in the Treatment of Fanconi Anemia,” in ThomasE. D.BlumeK. G.FormanS. J., eds., Hematopoietic Cell Transplantation (Malden, MA: Blackwell Science, 1999): 1204–1219.
34.
PenningsG.SchotsR.LiebaersI., “Ethical Considerations on Preimplantation Genetic Diagnosis for HLA Typing to Match a Future Child as a Donor of Haematopoietic Stem Cells to a Sibling,”Human Reproduction17, no. 3 (2002): 534–538.
35.
AuerbachA. D., “Umbilical Cord Transplants for Genetic Disease: Diagnostic and Ethical Issues in Fetal Studies,”Blood Cells20, nos. 2–3 (1994): 303–309.
36.
WolfS.KahnJ.WagnerJ., “Using Preimplantation Genetic Diagnosis to Create a Stem Cell Donor: Issues, Guidelines & Limits,”Journal of Law, Medicine & Ethics31, no. 3 (2003): 327–339.
37.
FeinsteinM., Iggrot Moshe (The Letters of Moses), vol. 3 (New York: Moriyah, 1959): At letter 90.
38.
Genesis 1:28.
39.
RosnerF., Biomedical Ethics and Jewish Law (Hoboken, NJ: Ktav Publishing, 2001): 165–173.
40.
SchenkerJ., “Gender Selection: Cultural and Religious Perspectives,”Journal of Assisted Reproduction and Genetics19, no. 9 (September 2002): 400–410; GraziR.WolowelskyJ., “Genetic Screening and Preimplantation Sex Selection in Halakhah,”Le'ela36 (Summer 1993), available at <http://www.daat.ac.il/daat/english/ethic/genetic_1.htm> (last visited August 21, 2007).
41.
Id. (Grazi and Wolowelsky), at responsa of Yigal Shafran and Yitzhak Zilberman.